StockData
Haemonetics Corp logo

Haemonetics Corp (HAE) stock

HAENYSESurgical & Medical Instruments & ApparatusFiscal year ends April 3
Financials through Q1 FY2027, quarter ended Jun 27, 2026Last filing: 10-Q on Nov 5, 2026Score 7/3073% above fair value
$120.92−0.42 (-0.35%)

Close on Nov 17, 2026Market cap $5.50BP/E 59.0Yield –

Haemonetics pe ratio

The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.

Haemonetics's pe ratio was 53.8× on Nov 11, 2026, against 23.8× a year earlier. Over the last 5 years it ranged from 14.9× to 147.0×, with a median of 36.3×.

PE Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 202653.8×+30.4
2025Dec 31, 202523.4×−9.0
2024Dec 31, 202432.4×−1.9
2023Dec 29, 202334.3×−13.0
2022Dec 30, 202247.4×−41.0
2021Dec 31, 202188.4×+31.0
2020Dec 31, 202057.4×−31.0
2019Dec 31, 201988.4×−161.7
2018Dec 31, 2018250.1×−475.9
2017Dec 29, 2017726.0×+661.4
2016Jan 29, 201664.6×−1.2
2015Dec 31, 201565.8×+0.1
2014Dec 31, 201465.6×−4.6
2013Dec 31, 201370.2×+30.6
2012Dec 31, 201239.6×+17.5
2011Dec 30, 201122.2×−3.9
2010Dec 31, 201026.1×+1.8
2009Dec 31, 200924.3×–

More Haemonetics figures

See a number that looks wrong?